NewsBenzingaRBC Capital mantiene la raccomandazione Outperform su Verastem, abbassa il prezzo obiettivo a 18 dollari RBC Capital mantiene la raccomandazione Outperform su Verastem, abbassa il prezzo obiettivo a 18 dollari Benzinga 2026.11.06 19:16 (GMT+0) Open on Benzinga Other news DA Davidson Maintains Buy on PDF Solutions, Lowers Price Target to $60 Needham Maintains Buy on Docebo, Raises Price Target to $42 DA Davidson Maintains Neutral on Rivian Automotive, Lowers Price Target to $15 IBM Demonstrates Quantum Computer IBM Quantum System Two In Chicago DA Davidson Maintains Buy on SoundHound AI, Lowers Price Target to $5 Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today
